Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000366142 | SCV000336880 | uncertain significance | not provided | 2015-11-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000539726 | SCV000641237 | uncertain significance | Congenital myasthenic syndrome 4A | 2022-09-13 | criteria provided, single submitter | clinical testing | This variant, c.1077_1079dup, results in the insertion of 1 amino acid(s) of the CHRNE protein (p.Pro360dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs752226476, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. ClinVar contains an entry for this variant (Variation ID: 465852). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002497128 | SCV002804979 | uncertain significance | Congenital myasthenic syndrome 4A; Congenital myasthenic syndrome 4C; Congenital myasthenic syndrome 4B | 2021-07-28 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000366142 | SCV003830636 | uncertain significance | not provided | 2019-06-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000366142 | SCV005384434 | uncertain significance | not provided | 2024-04-23 | criteria provided, single submitter | clinical testing | In-frame insertion of 1 amino acids in a non-repeat region; Has not been previously published as pathogenic or benign to our knowledge |
Natera, |
RCV001276701 | SCV001463210 | uncertain significance | Congenital myasthenic syndrome | 2020-01-17 | no assertion criteria provided | clinical testing |